Experiments from multiple groups have suggested that diabetes-accelerated atherosclerosis in mouse models may be mitigated by deletion of Ager (globally or in bone marrow-derived cells) [74–76] or by pharmacological agents directed to RAGE ligands and RAGE, such as sRAGE and anti-RAGE antibodies [77–79]. Here, AGER is linked to atherosclerosis.